Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Honig

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Lancet (London, England)|March 31, 2004
Merck Sharp and Dohme versus LaportePeter Honig
Clinical Pharmacology and Therapeutics|March 19, 2019
Regulation and Innovation: Role of Regulatory Science in Facilitating Pharmaceutical InnovationPeter Honig, Lei Zhang
The New England Journal of Medicine|January 18, 2006
Medicare and cost-effectiveness analysisMarc Berger, Peter Honig, Ian Spatz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2002
Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting SystemDouglas Shaffer, Sarah Singer, Joyce Korvick, et al.
Nature Reviews. Drug Discovery|September 5, 2020
COVID-19 must catalyse changes to clinical developmentRod MacKenzie, Peter Honig, Judy Sewards, et al.
Clinical Pharmacology and Therapeutics|August 9, 2020
Use of Real-World Data to Emulate a Clinical Trial and Support Regulatory Decision Making: Assessing the Impact of Temporality, Comparator Choice, and Method of AdjustmentDevin Abrahami, Richeek Pradhan, Hui Yin, et al.
Pharmacoepidemiology and Drug Safety|May 8, 2003
Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaignDouglas Shaffer, George Armstrong, Karen Higgins, et al.
Nature Reviews. Drug Discovery|February 15, 2023
Application of Bayesian approaches in drug development: starting a virtuous cycleStephen J Ruberg, Francois Beckers, Rob Hemmings, et al.
The American Journal of Cardiology|December 31, 2002
Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000Sana M Al-Khatib, Nancy M Allen LaPointe, Lesley H Curtis, et al.
Clinical Pharmacology and Therapeutics|January 30, 2004
Drug interactions with herbal products and grapefruit juice: a conference reportShiew-Mei Huang, Stephen D Hall, Paul Watkins, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Lancet (London, England)|March 31, 2004
Merck Sharp and Dohme versus LaportePeter Honig
Clinical Pharmacology and Therapeutics|March 19, 2019
Regulation and Innovation: Role of Regulatory Science in Facilitating Pharmaceutical InnovationPeter Honig, Lei Zhang
The New England Journal of Medicine|January 18, 2006
Medicare and cost-effectiveness analysisMarc Berger, Peter Honig, Ian Spatz
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 28, 2002
Concomitant risk factors in reports of torsades de pointes associated with macrolide use: review of the United States Food and Drug Administration Adverse Event Reporting SystemDouglas Shaffer, Sarah Singer, Joyce Korvick, et al.
Nature Reviews. Drug Discovery|September 5, 2020
COVID-19 must catalyse changes to clinical developmentRod MacKenzie, Peter Honig, Judy Sewards, et al.
Clinical Pharmacology and Therapeutics|August 9, 2020
Use of Real-World Data to Emulate a Clinical Trial and Support Regulatory Decision Making: Assessing the Impact of Temporality, Comparator Choice, and Method of AdjustmentDevin Abrahami, Richeek Pradhan, Hui Yin, et al.
Pharmacoepidemiology and Drug Safety|May 8, 2003
Increased US prescription trends associated with the CDC Bacillus anthracis antimicrobial postexposure prophylaxis campaignDouglas Shaffer, George Armstrong, Karen Higgins, et al.
Nature Reviews. Drug Discovery|February 15, 2023
Application of Bayesian approaches in drug development: starting a virtuous cycleStephen J Ruberg, Francois Beckers, Rob Hemmings, et al.
The American Journal of Cardiology|December 31, 2002
Outpatient prescribing of antiarrhythmic drugs from 1995 to 2000Sana M Al-Khatib, Nancy M Allen LaPointe, Lesley H Curtis, et al.
Clinical Pharmacology and Therapeutics|January 30, 2004
Drug interactions with herbal products and grapefruit juice: a conference reportShiew-Mei Huang, Stephen D Hall, Paul Watkins, et al.
Pageof 2